Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study. — CFSMEATLAS
Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study.
Mirfazeli, Fatemeh Sadat, Sarabi-Jamab, Atiye, Pereira-Sanchez, Victor et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022 · DOI
Quick Summary
This study followed 95 COVID-19 patients for 9 months to see which ones developed long-COVID symptoms like fatigue and brain fog. The most common symptom was extreme tiredness (affecting about half the patients), followed by anxiety, shortness of breath, and headaches. Interestingly, how sick someone was during acute COVID didn't predict whether they'd have long-COVID problems—but certain early warning signs (like psychiatric symptoms during the acute phase) did predict who would develop chronic fatigue and memory problems later.
Why It Matters
This research identifies potential biomarkers and risk factors for post-viral fatigue syndromes emerging after COVID-19, which is relevant for ME/CFS patients since long-COVID-associated fatigue resembles ME/CFS. Understanding that early neuropsychiatric symptoms predict later chronic fatigue and cognitive impairment could help clinicians identify high-risk patients and tailor early interventions. The findings suggest that post-viral fatigue mechanisms may relate to early CNS involvement rather than acute disease severity.
Observed Findings
Easy fatigability was the most common long-COVID symptom at 51.04% of patients, followed equally by anxiety, dyspnea, and new-onset headache (each 38.54%)
Acute COVID-19 severity did not significantly predict the number of long-COVID symptoms or cognitive dysfunction at 9 months
Female sex, higher number of acute symptoms, and constitutional neuropsychiatric symptoms in acute phase were independently associated with chronic fatigue syndrome at follow-up
Acute-phase constitutional neuropsychiatric symptoms were significantly associated with lower MoCA scores at 9-month follow-up (p=0.001)
Being female showed the strongest association with CFS development (p=0.02)
Inferred Conclusions
Constitutional neuropsychiatric manifestations during acute COVID-19 are a significant clinical predictor of debilitating long-COVID symptoms, particularly CFS and cognitive deficits
Acute disease severity alone is not a reliable predictor of long-COVID outcomes, suggesting that early CNS involvement may be more important than systemic inflammation burden
Female patients with multiple acute-phase symptoms and neuropsychiatric involvement warrant closer clinical monitoring for chronic fatigue and cognitive complications
Remaining Questions
What biological mechanisms explain why acute neuropsychiatric symptoms predict chronic fatigue and cognitive dysfunction—is this related to viral neuroinvasion, immune dysregulation, or blood-brain barrier compromise?
What This Study Does Not Prove
This study does not prove that psychiatric symptoms during acute illness *cause* chronic fatigue or cognitive deficits—only that they are associated. The lack of a control group limits generalizability. Additionally, the study cannot determine why acute neuropsychiatric symptoms predict later CFS, nor does it clarify the biological mechanisms underlying post-COVID fatigue. Cognitive decline is measured only by MoCA, which may not detect subtle cognitive changes relevant to ME/CFS.
Tags
Symptom:Cognitive DysfunctionFatigue
Phenotype:Long COVID Overlap
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleMixed Cohort